The European pharmaceutical industry federation EFPIA has published a report outlining a set of “clear and actionable recommendations” for improving the EU pharmaceutical legislation to “enable rapid patient access to medicines without compromising safety.”
The report, called Evidence MIX: Evaluating the EU Regulatory System, is part of EFPIA’s response to the European Commission’s Pharmaceutical Strategy, in particular a proposal for a wholesale revision of the EU medicines legislation, which is expected at the end of this year
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?